Effectiveness of the Health Literacy Promotion Program to Prevent Chronic Kidney Disease of Patients Who Use Polypharmacy
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 104
- 试验地点
- 1
研究概览
简要总结
This study aims to evaluate the effectiveness of a health literacy promotion program in preventing chronic kidney disease (CKD) among patients who use multiple medications (polypharmacy). Participants will be divided into two groups: an experimental group receiving the health literacy program and a control group receiving standard care. The study will measure improvements in health literacy levels and CKD prevention behaviors over a specific period. It is expected that the program will help patients better manage their medications and reduce the risk of developing kidney complications.
详细描述
Background: Patients with polypharmacy are at a higher risk of drug-induced kidney injury. Enhancing health literacy is a key strategy to empower these patients to engage in protective health behaviors.
Objectives: 1) To compare health literacy scores before and after participating in the program. 2) To compare CKD prevention behaviors between the experimental and control groups.
Methodology: This is a quasi-experimental study with a pre-test/post-test design.
Experimental Group: Receives the "Health Literacy Promotion Program," which includes educational sessions, skill-building for medication management, and follow-up support.
Control Group: Receives routine nursing care and standard health education. Intervention Details: The program focuses on 6 aspects of health literacy: access, understanding, communication, questioning, decision-making, and practice.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Single (Outcomes Assessor)
盲法说明
The outcome assessor, who is responsible for data collection and evaluation, is blinded to the group assignment to minimize assessment bias.
入排标准
- 年龄范围
- 55 Years 至 74 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients aged 55-74 years diagnosed with non-communicable diseases.
- •Currently taking 5 or more medications daily (Polypharmacy) for at least 6 months.
- •Have at least one risk factor for chronic kidney disease (e.g., Hypertension or Diabetes).
- •Able to communicate, read, and write in Thai.
- •Willing to participate in the 8-week program and follow-up assessments.
排除标准
- •Patients already diagnosed with Chronic Kidney Disease (CKD) stage 3 -
- •Having severe cognitive impairment or psychiatric disorders that prevent participation.
- •Having severe complications or being in an unstable clinical condition.
- •Planning to move out of the study area during the 12-week study period.
研究者
Wanpen Waelveerakup
Associate Professor
Nakhon Pathom Rajabhat University